TG Forum Logo TG Forum Logo

The SHASTA-2 trial: What the results mean for clinicians

You are here: Home > Expert Commentaries
Daniel Gaudet
Daniel Gaudet

Professor Daniel Gaudet, University of Montreal, Canada

Please login or create a FREE account to view this content

Børge G Nordestgaard

Triglyceride metabolism and mortality: What is the link?

Elias Bjornson

Are remnants more atherogenic than LDL? Novel genetic insights

Eliot Brinton

Evinacumab in children with HoFH: What’s the evidence?

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo